{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:20Z","timestamp":1793726480875,"version":"4.6.1"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1038\/s41584-024-01119-3","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:02:25Z","timestamp":1718622145000},"page":"459-472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Platelets in Kawasaki disease: mediators of vascular inflammation"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-8928","authenticated-orcid":false,"given":"Magali","family":"Noval Rivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-6055","authenticated-orcid":false,"given":"Beg\u00fcm","family":"Kocat\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo S.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-2909","authenticated-orcid":false,"given":"Moshe","family":"Arditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"1119_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle, B. W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease:\u00a0a scientific statement for health professionals from the American Heart Association. Circulation 135, e927\u2013e999 (2017).","journal-title":"Circulation"},{"key":"1119_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11926-020-0882-1","volume":"22","author":"PR Soni","year":"2020","unstructured":"Soni, P. R., Noval Rivas, M. & Arditi, M. A comprehensive update on Kawasaki disease vasculitis and myocarditis. Curr. Rheumatol. Rep. 22, 6 (2020).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1119_CR3","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16, 178\u2013222 (1967).","journal-title":"Arerugi"},{"key":"1119_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038998","volume":"7","author":"JM Orenstein","year":"2012","unstructured":"Orenstein, J. M. et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE\u00a07, e38998 (2012).","journal-title":"PLoS ONE"},{"key":"1119_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1756-185X.13219","volume":"21","author":"A Dionne","year":"2017","unstructured":"Dionne, A. & Dahdah, N. Myocarditis and Kawasaki disease. Int. J. Rheum. Dis. 21, 45\u201349 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"1119_CR6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jacc.2009.11.067","volume":"55","author":"N Dahdah","year":"2010","unstructured":"Dahdah, N. Not just coronary arteritis, Kawasaki disease is a myocarditis, too. J. Am. Coll. Cardiol. 55, 1507 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1119_CR7","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.111.082107","volume":"125","author":"LB Daniels","year":"2012","unstructured":"Daniels, L. B. et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation 125, 2447\u20132453 (2012).","journal-title":"Circulation"},{"key":"1119_CR8","first-page":"101039","volume":"40","author":"LB Daniels","year":"2022","unstructured":"Daniels, L. B. et al. Long-term health outcomes in young adults after Kawasaki disease. Int. J. Cardiol. Heart Vasc. 40, 101039 (2022).","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"1119_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jcin.2015.12.011","volume":"9","author":"JB Gordon","year":"2016","unstructured":"Gordon, J. B. et al. The spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease. JACC Cardiovasc. Interv. 9, 687\u2013696 (2016).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1119_CR10","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.jacc.2009.04.102","volume":"54","author":"JB Gordon","year":"2009","unstructured":"Gordon, J. B., Kahn, A. M. & Burns, J. C. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J. Am. Coll. Cardiol. 54, 1911\u20131920 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1119_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41577-023-00869-7","volume":"23","author":"M Scherlinger","year":"2023","unstructured":"Scherlinger, M., Richez, C., Tsokos, G. C., Boilard, E. & Blanco, P. The role of platelets in immune-mediated inflammatory diseases. Nat. Rev. Immunol. 23, 409 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1119_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3389\/fimmu.2019.01320","volume":"10","author":"LS Ribeiro","year":"2019","unstructured":"Ribeiro, L. S., Migliari Branco, L. & Franklin, B. S. Regulation of innate immune responses by platelets. Front. Immunol. 10, 1320 (2019).","journal-title":"Front. Immunol."},{"key":"1119_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas, M. & Arditi, M. Kawasaki disease: pathophysiology and insights from mouse models. Nat. Rev. Rheumatol. 16, 391\u2013405 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1119_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-12-r261","volume":"8","author":"SJ Popper","year":"2007","unstructured":"Popper, S. J. et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol. 8, R261 (2007).","journal-title":"Genome Biol."},{"key":"1119_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0102-6","volume":"6","author":"LT Hoang","year":"2014","unstructured":"Hoang, L. T. et al. Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med. 6, 541 (2014).","journal-title":"Genome Med."},{"key":"1119_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197858","volume":"13","author":"P Jaggi","year":"2018","unstructured":"Jaggi, P. et al. Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki disease. PLoS ONE\u00a013, e0197858 (2018).","journal-title":"PLoS ONE"},{"key":"1119_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25771-5","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. Nat. Commun. 12, 5444 (2021).","journal-title":"Nat. Commun."},{"key":"1119_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","volume":"11","author":"ST Shulman","year":"2015","unstructured":"Shulman, S. T. & Rowley, A. H. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat. Rev. Rheumatol. 11, 475\u2013482 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1119_CR19","doi-asserted-by":"publisher","first-page":"107303","DOI":"10.1016\/j.carpath.2020.107303","volume":"51","author":"W Sato","year":"2021","unstructured":"Sato, W., Yokouchi, Y., Oharaseki, T., Asakawa, N. & Takahashi, K. The pathology of Kawasaki disease aortitis: a study of 37 cases. Cardiovasc. Pathol. 51, 107303 (2021).","journal-title":"Cardiovasc. Pathol."},{"key":"1119_CR20","doi-asserted-by":"publisher","first-page":"5946","DOI":"10.4049\/jimmunol.159.12.5946","volume":"159","author":"AH Rowley","year":"1997","unstructured":"Rowley, A. H., Eckerley, C. A., Jack, H. M., Shulman, S. T. & Baker, S. C. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J. Immunol. 159, 5946\u20135955 (1997).","journal-title":"J. Immunol."},{"key":"1119_CR21","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1086\/323155","volume":"184","author":"TJ Brown","year":"2001","unstructured":"Brown, T. J. et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J. Infect. Dis. 184, 940\u2013943 (2001).","journal-title":"J. Infect. Dis."},{"key":"1119_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yexmp.2007.01.007","volume":"83","author":"A Yilmaz","year":"2007","unstructured":"Yilmaz, A. et al. Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease. Exp. Mol. Pathol. 83, 93\u2013103 (2007).","journal-title":"Exp. Mol. Pathol."},{"key":"1119_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/1756-185X.13207","volume":"21","author":"K Takahashi","year":"2017","unstructured":"Takahashi, K., Oharaseki, T. & Yokouchi, Y. Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int. J. Rheum. Dis. 21, 31\u201335 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"1119_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0090-1229(88)90088-8","volume":"48","author":"S Furukawa","year":"1988","unstructured":"Furukawa, S. et al. Peripheral blood monocyte\/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin. Immunol. Immunopathol. 48, 247\u2013251 (1988).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"1119_CR25","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","volume":"2","author":"DY Leung","year":"1989","unstructured":"Leung, D. Y. et al. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 2, 1298\u20131302 (1989).","journal-title":"Lancet"},{"key":"1119_CR26","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1084\/jem.164.6.1958","volume":"164","author":"DY Leung","year":"1986","unstructured":"Leung, D. Y. et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J. Exp. Med. 164, 1958\u20131972 (1986).","journal-title":"J. Exp. Med."},{"key":"1119_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/art.42680","volume":"76","author":"KE Brodeur","year":"2024","unstructured":"Brodeur, K. E. et al. Elevation of IL-17 cytokines distinguishes Kawasaki disease from other pediatric inflammatory disorders. Arthritis Rheumatol. 76, 285\u2013292 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1119_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/s10165-004-0341-2","volume":"14","author":"N Kobayashi","year":"2004","unstructured":"Kobayashi, N. et al. Intravenous gamma-globulin therapy improves hypercytokinemia in the acute phase of Kawasaki disease. Mod. Rheumatol. 14, 447\u2013452 (2004).","journal-title":"Mod. Rheumatol."},{"key":"1119_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s10157-012-0734-z","volume":"17","author":"K Takahashi","year":"2013","unstructured":"Takahashi, K., Oharaseki, T., Yokouchi, Y., Naoe, S. & Saji, T. Kawasaki disease: basic and pathological findings. Clin. Exp. Nephrol. 17, 690\u2013693 (2013).","journal-title":"Clin. Exp. Nephrol."},{"key":"1119_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.310233","volume":"120","author":"M He","year":"2017","unstructured":"He, M. et al. miR-483 targeting of CTGF suppresses endothelial-to-mesenchymal transition: therapeutic implications in Kawasaki disease. Circ. Res. 120, 354\u2013365 (2017).","journal-title":"Circ. Res."},{"key":"1119_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.humpath.2012.05.004","volume":"44","author":"C Shimizu","year":"2013","unstructured":"Shimizu, C. et al. The role of TGF-\u03b2 and myofibroblasts in the arteritis of Kawasaki disease. Hum. Pathol. 44, 189\u2013198 (2013).","journal-title":"Hum. Pathol."},{"key":"1119_CR32","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","volume":"94","author":"H Kato","year":"1996","unstructured":"Kato, H. et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94, 1379\u20131385 (1996).","journal-title":"Circulation"},{"key":"1119_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0735-1097(95)00447-5","volume":"27","author":"A Suzuki","year":"1996","unstructured":"Suzuki, A. et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J. Am. Coll. Cardiol. 27, 291\u2013296 (1996).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1119_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.carpath.2015.02.006","volume":"24","author":"C Shimizu","year":"2015","unstructured":"Shimizu, C. et al. Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood. Cardiovasc. Pathol. 24, 310\u2013316 (2015).","journal-title":"Cardiovasc. Pathol."},{"key":"1119_CR35","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/01.ATV.0000095974.95122.EC","volume":"23","author":"DD Wagner","year":"2003","unstructured":"Wagner, D. D. & Burger, P. C. Platelets in inflammation and thrombosis. Arterioscler. Thromb. Vasc. Biol. 23, 2131\u20132137 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1083\/jcb.201304054","volume":"201","author":"KR Machlus","year":"2013","unstructured":"Machlus, K. R. & Italiano, J. E. Jr The incredible journey: from megakaryocyte development to platelet formation. J. Cell Biol. 201, 785\u2013796 (2013).","journal-title":"J. Cell Biol."},{"key":"1119_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","volume":"11","author":"JW Semple","year":"2011","unstructured":"Semple, J. W., Italiano, J. E. Jr. & Freedman, J. Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264\u2013274 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"1119_CR38","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1172\/JCI26891","volume":"115","author":"SR Patel","year":"2005","unstructured":"Patel, S. R., Hartwig, J. H. & Italiano, J. E. Jr The biogenesis of platelets from megakaryocyte proplatelets. J. Clin. Invest. 115, 3348\u20133354 (2005).","journal-title":"J. Clin. Invest."},{"key":"1119_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2141.1998.00584.x","volume":"100","author":"N Miura","year":"1998","unstructured":"Miura, N., Terai, M., Meng, Y. G., Sato, T. & Niimi, H. Serum thrombopoietin levels in Kawasaki disease. Br. J. Haematol. 100, 387\u2013388 (1998).","journal-title":"Br. J. Haematol."},{"key":"1119_CR40","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1055\/s-0037-1615022","volume":"79","author":"A Ishiguro","year":"1998","unstructured":"Ishiguro, A. et al. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. Thromb. Haemost. 79, 1096\u20131100 (1998).","journal-title":"Thromb. Haemost."},{"key":"1119_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.seminhematol.2014.10.003","volume":"52","author":"K Kaushansky","year":"2015","unstructured":"Kaushansky, K. Thrombopoiesis. Semin. Hematol. 52, 4\u201311 (2015).","journal-title":"Semin. Hematol."},{"key":"1119_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10238-018-00544-5","volume":"19","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm. Clin. Exp. Med. 19, 173\u2013181 (2019).","journal-title":"Clin. Exp. Med."},{"key":"1119_CR43","first-page":"337","volume":"76","author":"Y Ueno","year":"1989","unstructured":"Ueno, Y. et al. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. Clin. Exp. Immunol. 76, 337\u2013342 (1989).","journal-title":"Clin. Exp. Immunol."},{"key":"1119_CR44","first-page":"147","volume":"40","author":"T Matsubara","year":"1991","unstructured":"Matsubara, T. Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease. Arerugi 40, 147\u2013154 (1991).","journal-title":"Arerugi"},{"key":"1119_CR45","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM198812223192515","volume":"319","author":"CP Maury","year":"1988","unstructured":"Maury, C. P., Salo, E. & Pelkonen, P. Circulating interleukin-1 \u03b2 in patients with Kawasaki disease. N. Engl. J. Med. 319, 1670\u20131671 (1988).","journal-title":"N. Engl. J. Med."},{"key":"1119_CR46","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.4049\/jimmunol.1600388","volume":"197","author":"MP Alphonse","year":"2016","unstructured":"Alphonse, M. P. et al. Inositol-triphosphate 3-kinase c mediates inflammasome activation and treatment response in Kawasaki disease. J. Immunol. 197, 3481\u20133489 (2016).","journal-title":"J. Immunol."},{"key":"1119_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature21706","volume":"544","author":"E Lefran\u00e7ais","year":"2017","unstructured":"Lefran\u00e7ais, E. et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544, 105\u2013109 (2017).","journal-title":"Nature"},{"key":"1119_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137377","volume":"131","author":"DN Pariser","year":"2021","unstructured":"Pariser, D. N. et al. Lung megakaryocytes are immune modulatory cells. J. Clin. Invest. 131, e137377 (2021).","journal-title":"J. Clin. Invest."},{"key":"1119_CR49","doi-asserted-by":"publisher","first-page":"100053","DOI":"10.1016\/j.rpth.2023.100053","volume":"7","author":"AC Livada","year":"2023","unstructured":"Livada, A. C., Pariser, D. N. & Morrell, C. N. Megakaryocytes in the lung: history and future perspectives. Res. Pract. Thromb. Haemost. 7, 100053 (2023).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"1119_CR50","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/jcp.39.9.969","volume":"39","author":"GK Sharma","year":"1986","unstructured":"Sharma, G. K. & Talbot, I. C. Pulmonary megakaryocytes: \u201cmissing link\u201d between cardiovascular and respiratory disease? J. Clin. Pathol. 39, 969\u2013976 (1986).","journal-title":"J. Clin. Pathol."},{"key":"1119_CR51","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1182\/blood.V26.6.720.720","volume":"26","author":"RM Kaufman","year":"1965","unstructured":"Kaufman, R. M., Airo, R., Pollack, S. & Crosby, W. H. Circulating megakaryocytes and platelet release in the lung. Blood 26, 720\u2013731 (1965).","journal-title":"Blood"},{"key":"1119_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0024-3205(89)90043-X","volume":"45","author":"S Nakai","year":"1989","unstructured":"Nakai, S., Aihara, K. & Hirai, Y. Interleukin-1 potentiates granulopoiesis and thrombopoiesis by producing hematopoietic factors in vivo. Life Sci. 45, 585\u2013591 (1989).","journal-title":"Life Sci."},{"key":"1119_CR53","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1182\/blood.V76.12.2493.2493","volume":"76","author":"H Kimura","year":"1990","unstructured":"Kimura, H. et al. Interleukin-1 \u03b2 (IL-1 \u03b2) induces thrombocytosis in mice: possible implication of IL-6. Blood 76, 2493\u20132500 (1990).","journal-title":"Blood"},{"key":"1119_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lab.2003.09.006","volume":"143","author":"CK Chuen","year":"2004","unstructured":"Chuen, C. K. et al. Interleukin-1\u03b2 up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells. J. Lab. Clin. Med. 143, 75\u201388 (2004).","journal-title":"J. Lab. Clin. Med."},{"key":"1119_CR55","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/ATVBAHA.113.302700","volume":"34","author":"LM Beaulieu","year":"2014","unstructured":"Beaulieu, L. M. et al. Interleukin 1 receptor 1 and interleukin 1\u03b2 regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler. Thromb. Vasc. Biol. 34, 552\u2013564 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825892","volume":"13","author":"F Cognasse","year":"2022","unstructured":"Cognasse, F. et al. Platelets as key factors in inflammation: focus on CD40L\/CD40. Front. Immunol. 13, 825892 (2022).","journal-title":"Front. Immunol."},{"key":"1119_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002355","volume":"7","author":"BF Kraemer","year":"2011","unstructured":"Kraemer, B. F. et al. Novel anti-bacterial activities of \u03b2-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog. 7, e1002355 (2011).","journal-title":"PLoS Pathog."},{"key":"1119_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/09537104.2016.1243789","volume":"28","author":"AL Ambrosio","year":"2017","unstructured":"Ambrosio, A. L. & Di Pietro, S. M. Storage pool diseases illuminate platelet dense granule biogenesis. Platelets 28, 138\u2013146 (2017).","journal-title":"Platelets"},{"key":"1119_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-immunol-042718-041607","volume":"37","author":"CN Morrell","year":"2019","unstructured":"Morrell, C. N., Pariser, D. N., Hilt, Z. T. & Vega Ocasio, D. The platelet Napoleon complex \u2014 small cells, but big immune regulatory functions. Annu. Rev. Immunol. 37, 125\u2013144 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"1119_CR60","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.1256478","volume":"346","author":"V Sreeramkumar","year":"2014","unstructured":"Sreeramkumar, V. et al. Neutrophils scan for activated platelets to initiate inflammation. Science 346, 1234\u20131238 (2014).","journal-title":"Science"},{"key":"1119_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002459","volume":"14","author":"G Zuchtriegel","year":"2016","unstructured":"Zuchtriegel, G. et al. Platelets guide leukocytes to their sites of extravasation. PLoS Biol. 14, e1002459 (2016).","journal-title":"PLoS Biol."},{"key":"1119_CR62","doi-asserted-by":"publisher","first-page":"317ra196","DOI":"10.1126\/scitranslmed.aad5330","volume":"7","author":"J-E Alard","year":"2015","unstructured":"Alard, J.-E. et al. Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5. Sci. Transl Med. 7, 317ra196 (2015).","journal-title":"Sci. Transl Med."},{"key":"1119_CR63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/ATVBAHA.113.302919","volume":"34","author":"S Badrnya","year":"2014","unstructured":"Badrnya, S. et al. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arterioscler. Thromb. Vasc. Biol. 34, 571\u2013580 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR64","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta, R. et al. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol. Rev. 229, 152\u2013172 (2009).","journal-title":"Immunol. Rev."},{"key":"1119_CR65","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/35393","volume":"391","author":"V Henn","year":"1998","unstructured":"Henn, V. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591\u2013594 (1998).","journal-title":"Nature"},{"key":"1119_CR66","doi-asserted-by":"publisher","first-page":"11644","DOI":"10.3390\/ijms222111644","volume":"22","author":"M Szczuko","year":"2021","unstructured":"Szczuko, M., Kozio\u0142, I., Kotl\u0119ga, D., Brodowski, J. & Drozd, A. The role of thromboxane in the course and treatment of ischemic stroke: review. Int. J. Mol. Sci. 22, 11644 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1119_CR67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tmrv.2020.09.005","volume":"34","author":"A Maouia","year":"2020","unstructured":"Maouia, A., Rebetz, J., Kapur, R. & Semple, J. W. The immune nature of platelets revisited. Transf. Med. Rev. 34, 209\u2013220 (2020).","journal-title":"Transf. Med. Rev."},{"key":"1119_CR68","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"SR Clark","year":"2007","unstructured":"Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463\u2013469 (2007).","journal-title":"Nat. Med."},{"key":"1119_CR69","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1538-7836.2011.04193.x","volume":"9","author":"A Assinger","year":"2011","unstructured":"Assinger, A. et al. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J. Thromb. Haemost. 9, 799\u2013809 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"1119_CR70","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.4049\/jimmunol.158.7.3372","volume":"158","author":"G Andonegui","year":"1997","unstructured":"Andonegui, G. et al. Inhibition of human neutrophil apoptosis by platelets. J. Immunol. 158, 3372\u20133377 (1997).","journal-title":"J. Immunol."},{"key":"1119_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1074-7613(03)00177-8","volume":"19","author":"BD Elzey","year":"2003","unstructured":"Elzey, B. D. et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19, 9\u201319 (2003).","journal-title":"Immunity"},{"key":"1119_CR72","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.celrep.2019.06.062","volume":"28","author":"A Carestia","year":"2019","unstructured":"Carestia, A. et al. Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice. Cell Rep. 28, 896\u2013908.e895 (2019).","journal-title":"Cell Rep."},{"key":"1119_CR73","doi-asserted-by":"publisher","first-page":"107615","DOI":"10.1016\/j.celrep.2020.107615","volume":"31","author":"V Rolfes","year":"2020","unstructured":"Rolfes, V. et al. Platelets fuel the inflammasome activation of innate immune cells. Cell Rep. 31, 107615 (2020).","journal-title":"Cell Rep."},{"key":"1119_CR74","doi-asserted-by":"publisher","unstructured":"Hawwari, I. et al. Platelet-derived transcription factors license human monocyte inflammation. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.08.10.503291 (2023).","DOI":"10.1101\/2022.08.10.503291"},{"key":"1119_CR75","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.110.207480","volume":"30","author":"L Totani","year":"2010","unstructured":"Totani, L. & Evangelista, V. Platelet\u2013leukocyte interactions in cardiovascular disease and beyond. Arterioscler. Thromb. Vasc. Biol. 30, 2357\u20132361 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR76","doi-asserted-by":"publisher","first-page":"824112","DOI":"10.3389\/fcvm.2021.824112","volume":"8","author":"R Kaiser","year":"2021","unstructured":"Kaiser, R., Escaig, R., Erber, J. & Nicolai, L. Neutrophil\u2013platelet interactions as novel treatment targets in cardiovascular disease. Front. Cardiovasc. Med. 8, 824112 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1119_CR77","doi-asserted-by":"publisher","first-page":"960398","DOI":"10.3389\/fcvm.2023.960398","volume":"10","author":"CC Rolling","year":"2023","unstructured":"Rolling, C. C., Barrett, T. J. & Berger, J. S. Platelet\u2013monocyte aggregates: molecular mediators of thromboinflammation. Front. Cardiovasc. Med. 10, 960398 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"1119_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025595","volume":"6","author":"G Passacquale","year":"2011","unstructured":"Passacquale, G. et al. Monocyte\u2013platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS ONE\u00a06, e25595 (2011).","journal-title":"PLoS ONE"},{"key":"1119_CR79","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1161\/ATVBAHA.117.309856","volume":"37","author":"P Shi","year":"2017","unstructured":"Shi, P. et al. Platelet-specific p38\u03b1 deficiency improved cardiac function after myocardial infarction in mice. Arterioscler. Thromb. Vasc. Biol. 37, e185\u2013e196 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2019.08.019","volume":"143","author":"KV Abhilasha","year":"2019","unstructured":"Abhilasha, K. V. et al. p38 MAP-kinase inhibitor protects against platelet-activating factor-induced death in mice. Free Radic. Biol. Med. 143, 275\u2013287 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"1119_CR81","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.4049\/jimmunol.1900899","volume":"203","author":"A Margraf","year":"2019","unstructured":"Margraf, A. & Zarbock, A. Platelets in inflammation and resolution. J. Immunol. 203, 2357\u20132367 (2019).","journal-title":"J. Immunol."},{"key":"1119_CR82","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.3390\/ijms23158370","volume":"23","author":"F Scopelliti","year":"2022","unstructured":"Scopelliti, F., Cattani, C., Dimartino, V., Mirisola, C. & Cavani, A. Platelet derivatives and the immunomodulation of wound healing. Int. J. Mol. Sci. 23, 8370 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1119_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3657","volume":"4","author":"B Xiang","year":"2013","unstructured":"Xiang, B. et al. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat. Commun. 4, 264 (2013).","journal-title":"Nat. Commun."},{"key":"1119_CR84","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41586-023-06436-3","volume":"620","author":"AB Schroer","year":"2023","unstructured":"Schroer, A. B. et al. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature 620, 1071\u20131079 (2023).","journal-title":"Nature"},{"key":"1119_CR85","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gendis.2019.09.003","volume":"7","author":"K Arora","year":"2020","unstructured":"Arora, K., Guleria, S., Jindal, A. K., Rawat, A. & Singh, S. Platelets in Kawasaki disease: is this only a numbers game or something beyond? Genes Dis. 7, 62\u201366 (2020).","journal-title":"Genes Dis."},{"key":"1119_CR86","first-page":"1223","volume":"140","author":"JJ Corrigan Jr","year":"1986","unstructured":"Corrigan, J. J. Jr Kawasaki disease and the plight of the platelet. Am. J. Dis. Child. 140, 1223\u20131224, (1986).","journal-title":"Am. J. Dis. Child."},{"key":"1119_CR87","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00431-021-03966-8","volume":"180","author":"JH Park","year":"2021","unstructured":"Park, J. H. & Choi, H. J. Clinical implications of thrombocytosis in acute phase Kawasaki disease. Eur. J. Pediatr. 180, 1841\u20131846 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"1119_CR88","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0022-3476(84)80114-6","volume":"105","author":"JC Burns","year":"1984","unstructured":"Burns, J. C., Glode, M. P., Clarke, S. H., Wiggins, J. Jr. & Hathaway, W. E. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. J. Pediatr. 105, 206\u2013211 (1984).","journal-title":"J. Pediatr."},{"key":"1119_CR89","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1136\/bmj.290.6480.1456","volume":"290","author":"M Levin","year":"1985","unstructured":"Levin, M. et al. Platelet immune-complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Brit Med. J. 290, 1456\u20131460 (1985).","journal-title":"Brit Med. J."},{"key":"1119_CR90","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/INF.0b013e31822d4f56","volume":"30","author":"AH Tremoulet","year":"2011","unstructured":"Tremoulet, A. H. et al. Evolution of laboratory values in patients with Kawasaki disease. Pediatr. Infect. Dis. J. 30, 1022\u20131026 (2011).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1119_CR91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00442611","volume":"147","author":"T Hara","year":"1988","unstructured":"Hara, T. et al. Thrombocytopenia: a complication of Kawasaki disease. Eur. J. Pediatr. 147, 51\u201353 (1988).","journal-title":"Eur. J. Pediatr."},{"key":"1119_CR92","first-page":"857","volume":"6","author":"K Niwa","year":"1995","unstructured":"Niwa, K. et al. Thrombocytopenia: a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease. Coron. Artery Dis. 6, 857\u2013864 (1995).","journal-title":"Coron. Artery Dis."},{"key":"1119_CR93","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/INF.0000000000002563","volume":"39","author":"R Ae","year":"2020","unstructured":"Ae, R. et al. Platelet count variation and risk for coronary artery abnormalities in Kawasaki disease. Pediatr. Infect. Dis. J. 39, 197\u2013203 (2020).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1119_CR94","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1442-200X.2003.01810.x","volume":"45","author":"M Taki","year":"2003","unstructured":"Taki, M. et al. Spontaneous platelet aggregation in Kawasaki disease using the particle counting method. Pediatr. Int. 45, 649\u2013652 (2003).","journal-title":"Pediatr. Int."},{"key":"1119_CR95","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1253\/circj.CJ-12-1037","volume":"78","author":"T Yahata","year":"2014","unstructured":"Yahata, T., Suzuki, C., Yoshioka, A., Hamaoka, A. & Ikeda, K. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease. Circ. J. 78, 188\u2013193 (2014).","journal-title":"Circ. J."},{"key":"1119_CR96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2739\/kurumemedj.27.57","volume":"27","author":"T Yokoyama","year":"1980","unstructured":"Yokoyama, T., Kato, H. & Ichinose, E. Aspirin treatment and platelet function in Kawasaki disease. Kurume Med. J. 27, 57\u201361 (1980).","journal-title":"Kurume Med. J."},{"key":"1119_CR97","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bbrc.2010.01.040","volume":"392","author":"E Straface","year":"2010","unstructured":"Straface, E. et al. Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease. Biochem. Biophys. Res. Commun. 392, 426\u2013430 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1119_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54113-1","volume":"9","author":"X Zheng","year":"2019","unstructured":"Zheng, X., Wu, W., Zhang, Y. & Wu, G. Changes in and significance of platelet function and parameters in Kawasaki disease. Sci. Rep. 9, 17641 (2019).","journal-title":"Sci. Rep."},{"key":"1119_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/09537104.2011.586073","volume":"23","author":"R Liu","year":"2012","unstructured":"Liu, R., Gao, F., Huo, J. & Yi, Q. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets 23, 11\u201316 (2012).","journal-title":"Platelets"},{"key":"1119_CR100","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/08880010390243004","volume":"20","author":"Y Nofech-Mozes","year":"2003","unstructured":"Nofech-Mozes, Y. & Garty, B. Z. Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms. Pediatr. Hematol. Oncol. 20, 597\u2013601 (2003).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"1119_CR101","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi, T. et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113, 2606\u20132612 (2006).","journal-title":"Circulation"},{"key":"1119_CR102","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami, K. et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J. Pediatr. 149, 237\u2013240 (2006).","journal-title":"J. Pediatr."},{"key":"1119_CR103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano, T. et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur. J. Pediatr. 166, 131\u2013137 (2007).","journal-title":"Eur. J. Pediatr."},{"key":"1119_CR104","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/ijms17030278","volume":"17","author":"D Rigante","year":"2016","unstructured":"Rigante, D. et al. Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome. Int. J. Mol. Sci. 17, 278 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"1119_CR105","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1542\/peds.2008-1871","volume":"123","author":"JT Kanegaye","year":"2009","unstructured":"Kanegaye, J. T. et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 123, e783\u2013789, (2009).","journal-title":"Pediatrics"},{"key":"1119_CR106","doi-asserted-by":"crossref","unstructured":"Takahashi, M. in Kawasaki Disease: Current Understanding of the Mechanism and Evidence-Based Treatment (eds Saji, B. T. et al.) 355\u2013372 (Springer, 2017).","DOI":"10.1007\/978-4-431-56039-5_39"},{"key":"1119_CR107","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0022-3476(83)80300-X","volume":"102","author":"T Hidaka","year":"1983","unstructured":"Hidaka, T., Nakano, M., Ueta, T., Komatsu, Y. & Yamamoto, M. Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease. J. Pediatr. 102, 94\u201396 (1983).","journal-title":"J. Pediatr."},{"key":"1119_CR108","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2169\/naika.41.791","volume":"41","author":"K Yamada","year":"1978","unstructured":"Yamada, K., Fukumoto, T., Shinkai, A., Shirahata, A. & Meguro, T. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Nihon Ketsueki Gakkai Zasshi 41, 791\u2013802 (1978).","journal-title":"Nihon Ketsueki Gakkai Zasshi"},{"key":"1119_CR109","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","volume":"18","author":"K Stark","year":"2021","unstructured":"Stark, K. & Massberg, S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 18, 666\u2013682 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"1119_CR110","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1177\/0003319713502392","volume":"65","author":"M Laurito","year":"2014","unstructured":"Laurito, M. et al. Endothelial and platelet function in children with previous Kawasaki disease. Angiology 65, 716\u2013722 (2014).","journal-title":"Angiology"},{"key":"1119_CR111","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1136\/heartjnl-2015-307734","volume":"101","author":"V Shah","year":"2015","unstructured":"Shah, V. et al. Cardiovascular status after Kawasaki disease in the UK. Heart 101, 1646\u20131655 (2015).","journal-title":"Heart"},{"key":"1119_CR112","doi-asserted-by":"publisher","first-page":"981010","DOI":"10.3389\/fcvm.2022.981010","volume":"9","author":"Y Qiu","year":"2022","unstructured":"Qiu, Y., Zhang, Y., Li, Y., Hua, Y. & Zhang, Y. Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis. Front. Cardiovasc. Med. 9, 981010 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1119_CR113","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/01.CIR.94.9.2103","volume":"94","author":"R Dhillon","year":"1996","unstructured":"Dhillon, R. et al. Endothelial dysfunction late after Kawasaki disease. Circulation 94, 2103\u20132106 (1996).","journal-title":"Circulation"},{"key":"1119_CR114","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/15513819509026990","volume":"15","author":"JC Burns","year":"1995","unstructured":"Burns, J. C. et al. Conjunctival biopsy in patients with Kawasaki disease. Pediatr. Pathol. Lab. Med. 15, 547\u2013553 (1995).","journal-title":"Pediatr. Pathol. Lab. Med."},{"key":"1119_CR115","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/000992289002900613","volume":"29","author":"JE Irazuzta","year":"1990","unstructured":"Irazuzta, J. E., Elbl, F. & Rees, A. R. Factor VIII related antigen (von Willebrand\u2019s factor) in Kawasaki disease. Clin. Pediatr. 29, 347\u2013348 (1990).","journal-title":"Clin. Pediatr."},{"key":"1119_CR116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/INF.0000000000002047","volume":"38","author":"L Luo","year":"2019","unstructured":"Luo, L. et al. Serum levels of syndecan-1 in patients with Kawasaki disease. Pediatr. Infect. Dis. J. 38, 89\u201394 (2019).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1119_CR117","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1046\/j.1365-2249.2001.01608.x","volume":"125","author":"S Takeshita","year":"2001","unstructured":"Takeshita, S. et al. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin. Exp. Immunol. 125, 340\u2013344 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"1119_CR118","doi-asserted-by":"publisher","first-page":"802217","DOI":"10.3389\/fped.2022.802217","volume":"10","author":"F Tian","year":"2022","unstructured":"Tian, F. et al. Correlation between matrix metalloproteinases with coronary artery lesion caused by kawasaki disease. Front. Pediatr. 10, 802217 (2022).","journal-title":"Front. Pediatr."},{"key":"1119_CR119","first-page":"2187","volume":"3","author":"HM Verheul","year":"1997","unstructured":"Verheul, H. M. et al. Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res. 3, 2187\u20132190 (1997).","journal-title":"Clin. Cancer Res."},{"key":"1119_CR120","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.3390\/ijms22094871","volume":"22","author":"M Geindreau","year":"2021","unstructured":"Geindreau, M., Ghiringhelli, F. & Bruchard, M. Vascular endothelial growth factor, a key modulator of the anti-tumor immune response. Int. J. Mol. Sci. 22, 4871 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1119_CR121","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2141.2009.07922.x","volume":"148","author":"K Ueno","year":"2010","unstructured":"Ueno, K. et al. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. Br. J. Haematol. 148, 285\u2013292 (2010).","journal-title":"Br. J. Haematol."},{"key":"1119_CR122","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1203\/00006450-199810000-00021","volume":"44","author":"N Maeno","year":"1998","unstructured":"Maeno, N. et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr. Res. 44, 596\u2013599 (1998).","journal-title":"Pediatr. Res."},{"key":"1119_CR123","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s004310051300","volume":"159","author":"T Ohno","year":"2000","unstructured":"Ohno, T. et al. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur. J. Pediatr. 159, 424\u2013429 (2000).","journal-title":"Eur. J. Pediatr."},{"key":"1119_CR124","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9149(98)00864-9","volume":"83","author":"M Terai","year":"1999","unstructured":"Terai, M. et al. Vascular endothelial growth factor in acute Kawasaki disease. Am. J. Cardiol. 83, 337\u2013339 (1999).","journal-title":"Am. J. Cardiol."},{"key":"1119_CR125","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/09537104.2015.1083543","volume":"27","author":"JD Eicher","year":"2016","unstructured":"Eicher, J. D. et al. Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction. Platelets 27, 230\u2013239 (2016).","journal-title":"Platelets"},{"key":"1119_CR126","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1182\/blood-2011-03-339705","volume":"118","author":"JW Rowley","year":"2011","unstructured":"Rowley, J. W. et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118, e101\u2013e111 (2011).","journal-title":"Blood"},{"key":"1119_CR127","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169855","volume":"8","author":"B Kocat\u00fcrk","year":"2023","unstructured":"Kocat\u00fcrk, B. et al. Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis. JCI Insight 8, e169855 (2023).","journal-title":"JCI Insight"},{"key":"1119_CR128","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/CIRCRESAHA.120.316951","volume":"127","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Reduced platelet miR-223 induction in kawasaki disease leads to severe coronary artery pathology through a miR-223\/PDGFR\u03b2 vascular smooth muscle cell axis. Circ. Res. 127, 855\u2013873 (2020).","journal-title":"Circ. Res."},{"key":"1119_CR129","doi-asserted-by":"publisher","first-page":"E140","DOI":"10.1542\/peds.111.2.e140","volume":"111","author":"CL Wang","year":"2003","unstructured":"Wang, C. L. et al. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 111, E140\u2013E147 (2003).","journal-title":"Pediatrics"},{"key":"1119_CR130","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2147\/DDDT.S163705","volume":"12","author":"L Pi","year":"2018","unstructured":"Pi, L. et al. Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease. Drug Des. Devel. Ther. 12, 1353\u20131362 (2018).","journal-title":"Drug Des. Devel. Ther."},{"key":"1119_CR131","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/bjh.18531","volume":"200","author":"L Fu","year":"2023","unstructured":"Fu, L. et al. Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease. Br. J. Haematol. 200, 776\u2013791 (2023).","journal-title":"Br. J. Haematol."},{"key":"1119_CR132","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1442-200X.1983.tb01691.x","volume":"25","author":"Y Inamo","year":"1983","unstructured":"Inamo, Y. Studies on plasma thromboxane B2 levels in patients with Kawasaki disease; as an indicator of coronary aneurysm formation. Pediatr. Int. 25, 230\u2013236 (1983).","journal-title":"Pediatr. Int."},{"key":"1119_CR133","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2739\/kurumemedj.48.135","volume":"48","author":"J Furui","year":"2001","unstructured":"Furui, J. Soluble forms of P-, E- and L-selectin in children with Kawasaki disease. Kurume Med. J. 48, 135\u2013143 (2001).","journal-title":"Kurume Med. J."},{"key":"1119_CR134","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1651-2227.2002.tb00126.x","volume":"91","author":"J Furui","year":"2002","unstructured":"Furui, J. et al. Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions. Acta Paediatr. 91, 1183\u20131188 (2002).","journal-title":"Acta Paediatr."},{"key":"1119_CR135","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/jir.2019.0141","volume":"40","author":"L Yi","year":"2020","unstructured":"Yi, L., Zhang, J., Zhong, J. & Zheng, Y. Elevated levels of platelet activating factor and its acetylhydrolase indicate high risk of Kawasaki disease. J. Interferon Cytokine Res. 40, 159\u2013167 (2020).","journal-title":"J. Interferon Cytokine Res."},{"key":"1119_CR136","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fimmu.2014.00357","volume":"5","author":"HM Wilson","year":"2014","unstructured":"Wilson, H. M. SOCS proteins in macrophage polarization and function. Front. Immunol. 5, 357 (2014).","journal-title":"Front. Immunol."},{"key":"1119_CR137","doi-asserted-by":"publisher","first-page":"eaax0481","DOI":"10.1126\/scitranslmed.aax0481","volume":"11","author":"TJ Barrett","year":"2019","unstructured":"Barrett, T. J. et al. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis. Sci. Transl Med. 11, eaax0481 (2019).","journal-title":"Sci. Transl Med."},{"key":"1119_CR138","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/ATVBAHA.119.313863","volume":"40","author":"RA Porritt","year":"2020","unstructured":"Porritt, R. A. et al. Interleukin-1\u03b2-mediated sex differences in Kawasaki disease vasculitis development and response to treatment. Arterioscler. Thromb. Vasc. Biol. 40, 802\u2013818 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058159","volume":"8","author":"C Shimizu","year":"2013","unstructured":"Shimizu, C. et al. Differential expression of miR-145 in children with Kawasaki disease. PLoS ONE\u00a08, e58159 (2013).","journal-title":"PLoS ONE"},{"key":"1119_CR140","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1097\/INF.0000000000000449","volume":"33","author":"AH Rowley","year":"2014","unstructured":"Rowley, A. H. et al. A study of cardiovascular miRNA biomarkers for Kawasaki disease. Pediatr. Infect. Dis. J. 33, 1296\u20131299 (2014).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1119_CR141","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jaci.2016.04.050","volume":"138","author":"H-C Kuo","year":"2016","unstructured":"Kuo, H.-C. et al. Next-generation sequencing identifies micro-RNA-based biomarker panel for Kawasaki disease. J. Allergy Clin. Immunol. 138, 1227\u20131230 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1119_CR142","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","volume":"23","author":"R Ebina-Shibuya","year":"2023","unstructured":"Ebina-Shibuya, R. & Leonard, W. J. Role of thymic stromal lymphopoietin in allergy and beyond. Nat. Rev. Immunol. 23, 24\u201337 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1119_CR143","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1002\/art.39817","volume":"68","author":"ME Truchetet","year":"2016","unstructured":"Truchetet, M. E. et al. Platelets induce thymic stromal lymphopoietin production by endothelial cells: contribution to fibrosis in human systemic sclerosis. Arthritis Rheumatol. 68, 2784\u20132794 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1119_CR144","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijcard.2014.01.022","volume":"172","author":"D Pietraforte","year":"2014","unstructured":"Pietraforte, D. et al. Platelets in Kawasaki patients: two different populations with different mitochondrial functions. Int. J. Cardiol. 172, 526\u2013528 (2014).","journal-title":"Int. J. Cardiol."},{"key":"1119_CR145","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1253\/circj.CJ-14-1323","volume":"79","author":"K Ueno","year":"2015","unstructured":"Ueno, K. et al. Circulating platelet\u2013neutrophil aggregates play a significant role in Kawasaki disease. Circ. J. 79, 1349\u20131356 (2015).","journal-title":"Circ. J."},{"key":"1119_CR146","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12969-021-00515-3","volume":"19","author":"P Vignesh","year":"2021","unstructured":"Vignesh, P. et al. Monocyte platelet aggregates in children with Kawasaki disease- a preliminary study from a tertiary care centre in North-West India. Pediatr. Rheumatol. Online J. 19, 25 (2021).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"1119_CR147","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1119_CR148","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/09537104.2018.1430358","volume":"29","author":"M Finsterbusch","year":"2018","unstructured":"Finsterbusch, M., Schrottmaier, W. C., Kral-Pointner, J. B., Salzmann, M. & Assinger, A. Measuring and interpreting platelet\u2013leukocyte aggregates. Platelets 29, 677\u2013685 (2018).","journal-title":"Platelets"},{"key":"1119_CR149","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000444807","volume":"43","author":"JB Kral","year":"2016","unstructured":"Kral, J. B., Schrottmaier, W. C., Salzmann, M. & Assinger, A. Platelet interaction with innate immune cells. Transfus. Med. Hemother. 43, 78\u201388 (2016).","journal-title":"Transfus. Med. Hemother."},{"key":"1119_CR150","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2018.12.029","volume":"282","author":"N Allen","year":"2019","unstructured":"Allen, N. et al. Circulating monocyte\u2013platelet aggregates are a robust marker of platelet activity in cardiovascular disease. Atherosclerosis 282, 11\u201318 (2019).","journal-title":"Atherosclerosis"},{"key":"1119_CR151","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1067\/mcp.2003.13","volume":"73","author":"U Klinkhardt","year":"2003","unstructured":"Klinkhardt, U. et al. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet\u2013leukocyte aggregates in patients with atherosclerotic vascular disease. Clin. Pharmacol. Ther. 73, 232\u2013241 (2003).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1119_CR152","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1172\/JCI20986","volume":"113","author":"RT Dorsam","year":"2004","unstructured":"Dorsam, R. T. & Kunapuli, S. P. Central role of the P2Y12 receptor in platelet activation. J. Clin. Invest. 113, 340\u2013345 (2004).","journal-title":"J. Clin. Invest."},{"key":"1119_CR153","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1055\/s-0042-1758655","volume":"123","author":"CC Rolling","year":"2023","unstructured":"Rolling, C. C. et al. P2Y12 inhibition suppresses proinflammatory platelet\u2013monocyte interactions. Thromb. Haemost. 123, 231\u2013244 (2023).","journal-title":"Thromb. Haemost."},{"key":"1119_CR154","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/art.1780280609","volume":"28","author":"TJ Lehman","year":"1985","unstructured":"Lehman, T. J., Walker, S. M., Mahnovski, V. & McCurdy, D. Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum. 28, 652\u2013659 (1985).","journal-title":"Arthritis Rheum."},{"key":"1119_CR155","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1348-0421.1979.tb02815.x","volume":"23","author":"H Murata","year":"1979","unstructured":"Murata, H. Experimental candida-induced arteritis in mice. Relation to arteritis in the mucocutaneous lymph node syndrome. Microbiol. Immunol. 23, 825\u2013831 (1979).","journal-title":"Microbiol. Immunol."},{"key":"1119_CR156","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/ATVBAHA.110.216325","volume":"31","author":"H Nishio","year":"2011","unstructured":"Nishio, H. et al. Nod1 ligands induce site-specific vascular inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 1093\u20131099 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR157","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.111.072769","volume":"125","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Interleukin-1\u03b2 is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease. Circulation 125, 1542\u20131550 (2012).","journal-title":"Circulation"},{"key":"1119_CR158","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1161\/CIRCRESAHA.121.319153","volume":"129","author":"RA Porritt","year":"2021","unstructured":"Porritt, R. A. et al. NLRP3 inflammasome mediates immune\u2013stromal interactions in vasculitis. Circ. Res. 129, e183\u2013e200 (2021).","journal-title":"Circ. Res."},{"key":"1119_CR159","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1253\/circj.CJ-13-0612","volume":"78","author":"IC Lin","year":"2014","unstructured":"Lin, I. C. et al. Vascular endothelial growth factor-a in Lactobacillus casei cell wall extract-induced coronary arteritis of a murine model. Circ. J. 78, 752\u2013762 (2014).","journal-title":"Circ. J."},{"key":"1119_CR160","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.yjmcc.2019.11.158","volume":"138","author":"F Anzai","year":"2019","unstructured":"Anzai, F. et al. Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease. J. Mol. Cell Cardiol. 138, 185\u2013196 (2019).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1119_CR161","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/ATVBAHA.115.306475","volume":"35","author":"Y Lee","year":"2015","unstructured":"Lee, Y. et al. IL-1 signaling is critically required in stromal cells in Kawasaki disease vasculitis mouse model: role of both IL-1\u03b1 and IL-1\u03b2. Arterioscler. Thromb. Vasc. Biol. 35, 2605\u20132616 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR162","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/ATVBAHA.115.307072","volume":"36","author":"D Wakita","year":"2016","unstructured":"Wakita, D. et al. Role of interleukin-1 signaling in a mouse model of Kawasaki disease-associated abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 36, 886\u2013897 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR163","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151981","volume":"6","author":"S Marek-Iannucci","year":"2021","unstructured":"Marek-Iannucci, S. et al. Autophagy\u2013mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis. JCI Insight 6, e151981 (2021).","journal-title":"JCI Insight"},{"key":"1119_CR164","doi-asserted-by":"publisher","first-page":"779","DOI":"10.15252\/emmm.201506046","volume":"8","author":"SH Lee","year":"2016","unstructured":"Lee, S. H. et al. Inducing mitophagy in diabetic platelets protects against severe oxidative stress. EMBO Mol. Med. 8, 779\u2013795 (2016).","journal-title":"EMBO Mol. Med."},{"key":"1119_CR165","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00281-019-00734-7","volume":"41","author":"MY Kimura","year":"2019","unstructured":"Kimura, M. Y., Koyama-Nasu, R., Yagi, R. & Nakayama, T. A new therapeutic target: the CD69\u2013Myl9 system in immune responses. Semin. Immunopathol. 41, 349\u2013358 (2019).","journal-title":"Semin. Immunopathol."},{"key":"1119_CR166","doi-asserted-by":"publisher","first-page":"1036672","DOI":"10.3389\/fimmu.2022.1036672","volume":"13","author":"H Kobayashi","year":"2022","unstructured":"Kobayashi, H. et al. Increased myosin light chain 9 expression during Kawasaki disease vasculitis. Front. Immunol. 13, 1036672 (2022).","journal-title":"Front. Immunol."},{"key":"1119_CR167","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/art.39975","volume":"69","author":"JC Burns","year":"2017","unstructured":"Burns, J. C. et al. Review: found in translation: international initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki disease. Arthritis Rheumatol. 69, 268\u2013276 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"1119_CR168","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fphar.2017.00163","volume":"8","author":"P Dusser","year":"2017","unstructured":"Dusser, P. & Kone-Paut, I. IL-1 inhibition may have an important role in treating refractory Kawasaki disease. Front. Pharmacol. 8, 163 (2017).","journal-title":"Front. Pharmacol."},{"key":"1119_CR169","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.autrev.2018.01.024","volume":"17","author":"I Kone-Paut","year":"2018","unstructured":"Kone-Paut, I. et al. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun. Rev. 17, 768\u2013774 (2018).","journal-title":"Autoimmun. Rev."},{"key":"1119_CR170","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","volume":"110","author":"JW Newburger","year":"2004","unstructured":"Newburger, J. W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110, 2747\u20132771 (2004).","journal-title":"Circulation"},{"key":"1119_CR171","first-page":"Cd004175","volume":"2006","author":"JH Baumer","year":"2006","unstructured":"Baumer, J. H. et al. Salicylate for the treatment of Kawasaki disease in children. Cochrane Database Syst. Rev. 2006, Cd004175 (2006).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1119_CR172","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0022-3476(97)70038-6","volume":"131","author":"M Terai","year":"1997","unstructured":"Terai, M. & Shulman, S. T. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J. Pediatr. 131, 888\u2013893 (1997).","journal-title":"J. Pediatr."},{"key":"1119_CR173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144603","volume":"10","author":"HC Kuo","year":"2015","unstructured":"Kuo, H. C., Lo, M. H., Hsieh, K. S., Guo, M. M. & Huang, Y. H. High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease. PLoS ONE\u00a010, e0144603 (2015).","journal-title":"PLoS ONE"},{"key":"1119_CR174","first-page":"209","volume":"35","author":"G Amarilyo","year":"2017","unstructured":"Amarilyo, G. et al. High-dose aspirin for Kawasaki disease: outdated myth or effective aid? Clin. Exp. Rheumatol. 35, 209\u2013212 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1119_CR175","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4070\/kcj.2013.43.3.182","volume":"43","author":"G Lee","year":"2013","unstructured":"Lee, G., Lee, S. E., Hong, Y. M. & Sohn, S. Is high-dose aspirin necessary in the acute phase of Kawasaki disease? Korean Circ. J. 43, 182\u2013186, (2013).","journal-title":"Korean Circ. J."},{"key":"1119_CR176","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1542\/peds.2017-0098","volume":"139","author":"F Dallaire","year":"2017","unstructured":"Dallaire, F. et al. Aspirin dose and prevention of coronary abnormalities in Kawasaki disease. Pediatrics 139, 249 (2017).","journal-title":"Pediatrics"},{"key":"1119_CR177","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1586\/1744666X.2015.1044980","volume":"11","author":"JC Burns","year":"2015","unstructured":"Burns, J. C. & Franco, A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev. Clin. Immunol. 11, 819\u2013825 (2015).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"1119_CR178","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/diagnostics13142338","volume":"13","author":"PL Nadig","year":"2023","unstructured":"Nadig, P. L. et al. Intravenous immunoglobulin in Kawasaki disease \u2014 evolution and pathogenic mechanisms. Diagnostics 13, 2338 (2023).","journal-title":"Diagnostics"},{"key":"1119_CR179","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147076","volume":"131","author":"YP Zhu","year":"2021","unstructured":"Zhu, Y. P. et al. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. J. Clin. Invest 131, e147046 (2021).","journal-title":"J. Clin. Invest"},{"key":"1119_CR180","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1442-200X.1991.tb02610.x","volume":"33","author":"M Inagaki","year":"1991","unstructured":"Inagaki, M. & Yamada, K. Inhibitory effects of high doses of intravenous gamma-globulin on platelet interaction with the vessel wall in Kawasaki disease. Acta Paediatr. Jpn 33, 791\u2013798 (1991).","journal-title":"Acta Paediatr. Jpn"},{"key":"1119_CR181","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.115.306528","volume":"35","author":"MR Thomas","year":"2015","unstructured":"Thomas, M. R. et al. Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler. Thromb. Vasc. Biol. 35, 2562\u20132570 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1119_CR182","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2016","unstructured":"Ataga, K. I. et al. Crizanlizumab for the prevention of pain crises in sickle cell disease. N. Engl. J. Med. 376, 429\u2013439 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1119_CR183","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2020.07.022","volume":"321","author":"T Low","year":"2020","unstructured":"Low, T. et al. Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease. Int. J. Cardiol. 321, 6\u201311 (2020).","journal-title":"Int. J. Cardiol."},{"key":"1119_CR184","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1203\/00006450-199804001-00136","volume":"43","author":"M Gupta","year":"1998","unstructured":"Gupta, M. et al. Serum interleukin-6 (IL-6) levels in children with Kawasaki\u2019s disease (KD) [abstract 115]. Pediatr. Res. 43, 22\u201322 (1998).","journal-title":"Pediatr. Res."},{"key":"1119_CR185","doi-asserted-by":"publisher","first-page":"630196","DOI":"10.3389\/fimmu.2021.630196","volume":"12","author":"RA Porritt","year":"2021","unstructured":"Porritt, R. A. et al. Inhibition of IL-6 in the LCWE mouse model of Kawasaki disease inhibits acute phase reactant serum amyloid A but fails to attenuate vasculitis. Front. Immunol. 12, 630196 (2021).","journal-title":"Front. Immunol."},{"key":"1119_CR186","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.yexmp.2006.05.006","volume":"82","author":"A Ishida-Okawara","year":"2007","unstructured":"Ishida-Okawara, A. et al. Neutrophil activation and arteritis induced by C. albicans water-soluble mannoprotein-\u03b2-glucan complex (CAWS). Exp. Mol. Pathol. 82, 220\u2013226 (2007).","journal-title":"Exp. Mol. Pathol."},{"key":"1119_CR187","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/14397595.2017.1287150","volume":"27","author":"R Ohashi","year":"2017","unstructured":"Ohashi, R. et al. Characterization of a murine model with arteritis induced by Nod1 ligand, FK565: a comparative study with a CAWS-induced model. Mod. Rheumatol. 27, 1024\u20131030 (2017).","journal-title":"Mod. Rheumatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01119-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:38:54Z","timestamp":1721903934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01119-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":187,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1038\/s41584-024-01119-3","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"22 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}